Israel : TEVA bags approval from FDA to market generic asthma treatment … – Equities.com


MedPage Today

Israel : TEVA bags approval from FDA to market generic asthma treatment
Equities.com
US Food and Drug Administration (FDA) have given its approval to Teva Pharmaceutical Industries Ltd. for generic versions of asthma and allergies treatment Singulair in adults and children. Made by Merck & Co., brand Singulair has $5 billion in annual
New generic Singulair could save asthma sufferers big bucksConsumerReports.org
Generic Singulair ApprovedWebMD
FDA approves generic versions of asthma, allergy drugDrug Store News
MedPage Today –RTT News –Jerusalem Post
all 52 news articles »

View full post on asthma – Google News

First generic versions of Singulair receive FDA approval for treatment of … – News-Medical.net


MedPage Today

First generic versions of Singulair receive FDA approval for treatment of
News-Medical.net
The U.S. Food and Drug Administration today approved the first generic versions of Singulair (montelukast sodium) for use in adults and children to control asthma symptoms and to help relieve symptoms of indoor and outdoor allergies. Montelukast is in
Teva asthma, allergy drug approved by FDAJerusalem Post
FDA Approves Generic Versions Of Singulair To Treat Asthma, AllergiesNASDAQ
Generic Singulair ApprovedWebMD
MedPage Today –Chicago Tribune –Columbus Dispatch
all 41 news articles »

View full post on asthma – Google News

FDA okays generic Singulair for asthma treatment – The Capitol Column


The Capitol Column

FDA okays generic Singulair for asthma treatment
The Capitol Column
The FDA announced Friday that it has approved the production of generic versions of Singulair, a drug used for the treatment of asthma and allergies. The patent on Singulair, or montelukast sodium, was held by Merck, and expired on Aug. 3, 2012. The
FDA Approves Generic Versions Of Singulair To Treat Asthma, AllergiesRTT News
FDA OKs generic SingulairChicago Tribune
Generic Singulair ApprovedWebMD
Globes –MedPage Today
all 37 news articles »

View full post on asthma – Google News

Asthma patients get fully funded treatment – Voxy


The Farming Show

Asthma patients get fully funded treatment
Voxy
New Zealand asthma patients will now have another fully funded treatment option thanks to Pharmac reimbursing Singulair (montelukast sodium) from 1 August 2012. New Zealand has one of the highest prevalence rates of asthma in the world, second only
PHARMAC to fund alternative treatments for asthma, scabiesScoop.co.nz (press release)
Pharmac funds new asthma treatment for preschoolersRadio New Zealand
Funding for alternative treatments for asthma, scabiesNewstalk ZB

all 8 news articles »

View full post on asthma – Google News